Preclinical studies and Phase I
In this channel, you can find the latest news and updates on lead candidates in preclinical and Phase I clinical trials.
Could a small molecule complement regenerative therapies in spinal cord injury?
How can we replace, refine and reduce the use of animals in research? An interview with Anthony Holmes
Spheroids and high-throughput screening: a method for identifying anticancer therapeutics
Natural antioxidants in hybrids for the treatment of neurodegenerative diseases: a successful strategy?
‘The ultimate validation of a target is a successful clinical trial’: an interview with Maya Ghoussaini
Challenges in the design of reliable immuno-oncology mouse models to inform drug development